Women’s healthcare technologies as an industry is impressively
growing, predicted to reach $60bn by 2027. However, global
political changes are beginning to pose critical risks to its
progress. These shifts can impact everything from funding flows and
clinical research priorities to bias in data encoded in the
technology we build. As such, it is critical to unpack how we can
build more resilient solutions for tomorrow. Join us for an evening of
sharp, candid discussion between visionaries all committed to
advancing resilience and equity in women’s health. Including
founders, investors, researchers, and operators. Taking the Stage
Dominick Kennerson, Director, HealthTech, Life Sciences & Healthcare,
HSBC Innovation Banking Sage Revell, Partner, Jones Day Dr. Molly
Gilmartin, Investment Director, AlbionVC Emilė Radytė, Founder &
CEO, Samphire Neuroscience Moderated by Maxence-Viktor Questions you
can expect... How are recent socio-political shifts in the UK, US, and
EU—from overturned protections to regulatory tightening—reshaping
the future of women’s health? What role do capital and legal
structures play in either reinforcing or breaking long-standing bias
against women-led and women-focused innovation? How can we rethink the
language, metrics, and power structures in healthcare to build trust
and truly serve more people? Provisional Agenda 4:30 PM - Attendees
arrive, refreshments served 5:15 PM - Welcome remarks & partner
introductions 5:30 PM - Panel discussion begins 6:30 PM - Audience
Q&A 6:40 PM - Networking with refreshments 7:30 PM - Close About the
Organisers Maxence-Viktor, founder of Health Concierge, an exciting
new initiative to propel women’s health (more to come soon…) Dr.
Valerie Cai, co-founder of XX Combinator solving data and funding
bottlenecks in women's health Nour Ben Gaied, data scientist at
Firemind, where she combines deep technical expertise with practical
innovation Seats are limited. Secure your spot for an evening of
insight and connection.
politics
95
Views
10/07/2025 Last update